CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project seeks to develop an AI-based software called LeukoScreen to automate the detection of acute leukemia in blood samples, enhancing diagnostic speed and accuracy. The goal is to support clinical decisions and improve patient outcomes in leukemia diagnostics.
Acute promyelocytic leukemia is an extremely aggressive blood cancer where immediate diagnosis can determine life or death.
The diagnostic state of the art is manual inspection of a patient’s blood smear under the microscope by trained cytologists.
It is prone to human error and time consuming - a risk factor in notoriously understaffed laboratories.
Supporting clinical decisions with AI will drastically increase diagnostic speed and accuracy, benefit patient survival, and free up valuable exper…
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, MUNCHEN
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
